Pharmaceutical Hot Melt Extrusions segmentation by type distinguishes Twin‑screw extruders, Single‑screw extruders, and Modular continuous‑flow systems, each contributing uniquely to market volume. Twin‑screw extruders, characterized by intermeshing rotors and high shear capacity, dominate the segment—approximately 60 % of equipment sales—because they enable precise temperature control and efficient mixing of high‑load APIs, supporting complex solid‑dispersion formulations. Single‑screw extruders, with a simpler barrel‑screw architecture, account for roughly 25 % of the market; they are favored for low‑viscosity polymers and cost‑sensitive production runs, offering lower capital outlay but limited process flexibility. Modular continuous‑flow systems, emerging as a niche yet rapidly growing category (about 15 % of revenue), integrate inline granulation, drying, and milling, thereby compressing the manufacturing footprint and enhancing scale‑up reliability for continuous‑manufacturing initiatives. The distribution of these types reflects manufacturers’ strategic trade‑offs between capital intensity, product complexity, and regulatory alignment, shaping the overall market size of pharmaceutical hot melt extrusions. Increasing adoption of Quality‑by‑Design frameworks is prompting a shift toward twin‑screw platforms equipped with real‑time PAT sensors, which is expected to raise their share modestly over the next five years.
